bcl-2

(redirected from Bcl-2 protein)
Also found in: Medical.

bcl-2

(biochemistry)
A family of proteins that operate in the effector phase of apoptosis and may either promote or inhibit apoptosis.
References in periodicals archive ?
Bcl-2 protein in the cytoplasm acts as inhibitor of apoptosis while Bax promotes apoptosis.
Bcl-2 protein ailesi apoptozisi inhibe eden (Bcl-2, Bcl-xL, Mcl-1, Bcl-w, A1/Bfl1 gibi) veya aktive eden (Bax, Bak, Bad, Bim, Bik, Noxa, Puma, Hrk gibi) birbirleri ile yuksek oranda yapisal homoloji gosteren proteinlerden meydana gelmis bir ailedir.
In some similar manner, Bax protein contents were significantly increased and Bcl-2 protein contents were concomitantly decreased in FA group compared to the control group (P < 0.
The induction of apoptosis by cathachunine occurred through an ROS-dependent mitochondria-mediated intrinsic pathway rather than an extrinsic pathway, and was regulated by the Bcl-2 protein family.
According to the company, VENCLEXTA is a small molecule inhibitor of the BCL-2 protein.
Venclexta is the first approved medicine designed to help restore a process in which cells self-destruct (apoptosis) by selectively blocking the BCL-2 protein and is Roches tenth new medicine approved in the past seven years.
PD treatment increased levels of Bcl-2 protein and reduced expression of the proapoptotic proteins PUMA-[alpha] and Bax and the cyto/mito ratio of cytochrome C and cleaved caspase-3, as well as apoptosis.
However, Bcl-2 protein expression has been reported to increase in a variety of human cancer and its precise biological role in the development of malignant tumors is still controversial (16-21).
Apoptosis, known as a programmed cell death, can occur in cellular organelles-associated way (mitochondrial pathway) that involves the Bcl-2 protein family.
The first Bcl-2 associated protein (BAG-1) was identified as partners of the anti-apoptotic BCL-2 protein (Takayama et al.